![Costas Karatzas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Costas Karatzas
Gründer bei Acesis BioMed US, Inc.
Vermögen: 103 $ am 31.08.2017
Profil
Costas Karatzas is the founder and currently serves as the Chief Executive Officer & Director of Acesis BioMed US, Inc. which he founded in 2015.
He previously held the position of Senior Vice President-Research & Development at Nexia Biotechnologies, Inc.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
Acesis BioMed US, Inc.
![]() Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. 30,76% | 31.03.2019 | 10 284 000 ( 30,76% ) | 103 $ | 31.08.2017 |
Aktive Positionen von Costas Karatzas
Unternehmen | Position | Beginn |
---|---|---|
Acesis BioMed US, Inc.
![]() Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | Gründer | 11.03.2015 |
Ehemalige bekannte Positionen von Costas Karatzas
Unternehmen | Position | Ende |
---|---|---|
Nexia Biotechnologies, Inc.
![]() Nexia Biotechnologies, Inc. BiotechnologyHealth Technology Nexia Biotechnologies produces therapeutic proteins and other biomaterials for the treatment of serious disease | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Acesis BioMed US, Inc.
![]() Acesis BioMed US, Inc. Pharmaceuticals: MajorHealth Technology IASO BioMed, Inc. operates as a developmental stage biotechnology company. It focuses on researching and developing a drug. The company founded on March 11, 2015 and is headquartered in Centennial, CO. | Health Technology |
Nexia Biotechnologies, Inc.
![]() Nexia Biotechnologies, Inc. BiotechnologyHealth Technology Nexia Biotechnologies produces therapeutic proteins and other biomaterials for the treatment of serious disease | Health Technology |